0000899243-18-014735.txt : 20180601 0000899243-18-014735.hdr.sgml : 20180601 20180601182956 ACCESSION NUMBER: 0000899243-18-014735 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180530 FILED AS OF DATE: 20180601 DATE AS OF CHANGE: 20180601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Francis Chris CENTRAL INDEX KEY: 0001657709 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37627 FILM NUMBER: 18876393 MAIL ADDRESS: STREET 1: C/O WAVE LIFE SCIENCES LTD. STREET 2: 733 CONCORD AVE. CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Wave Life Sciences Ltd. CENTRAL INDEX KEY: 0001631574 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: U0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7 STRAITS VIEW STREET 2: #12-00, MARINA ONE EAST TOWER CITY: SINGAPORE STATE: U0 ZIP: 018936 BUSINESS PHONE: 617-949-2900 MAIL ADDRESS: STREET 1: 733 CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 FORMER COMPANY: FORMER CONFORMED NAME: WAVE Life Sciences Ltd. DATE OF NAME CHANGE: 20170516 FORMER COMPANY: FORMER CONFORMED NAME: Wave Life Sciences Ltd. DATE OF NAME CHANGE: 20151106 FORMER COMPANY: FORMER CONFORMED NAME: Wave Life Sciences LTD. DATE OF NAME CHANGE: 20151106 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-30 0 0001631574 Wave Life Sciences Ltd. WVE 0001657709 Francis Chris C/O WAVE LIFE SCIENCES LTD., 733 CONCORD AVE. CAMBRIDGE MA 02138 0 1 0 0 See Remarks Ordinary Shares 2018-05-30 4 M 0 24496 2.48 A 46573 D Ordinary Shares 2018-05-30 4 S 0 24496 45.50 D 22077 D Ordinary Shares 2018-06-01 4 M 0 24496 2.48 A 46573 D Ordinary Shares 2018-06-01 4 S 0 24496 48.00 D 22077 D Share Option (right to buy) 2.48 2018-05-30 4 M 0 24496 0.00 D 2025-03-10 Ordinary Shares 24496 101564 D Share Option (right to buy) 2.48 2018-06-01 4 M 0 24496 0.00 D 2025-03-10 Ordinary Shares 24496 77068 D The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. The share option represented a right to purchase a total of 126,174 ordinary shares, 25% of which became exercisable on April 15, 2015, and the remaining shares vest in 36 equal monthly installments thereafter. SVP, Corporate Development, Head of Emerging Areas /s/ Chris Francis 2018-06-01